Dr. Kyoji Tsuchikama Study shows new technology to increase success rates in mouse-based anticancer drug evaluation

Researchers at the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM) have found a new way to reduce failure rates in pre-clinical studies of antibody-drug conjugates (ADCs) using mouse models.